These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12400857)

  • 21. Spiro-substituted piperidines as neurokinin receptor antagonists. III. Synthesis of (+/-)-N-[2-(3,4-dichlorophenyl)-4-(spiro-substituted piperidin-1'-yl)butyl]-N-methylbenzamides and evaluation of NK1-NK2 dual antagonistic activities.
    Kubota H; Kakefuda A; Okamoto Y; Fujii M; Yamamoto O; Yamagiwa Y; Orita M; Ikeda K; Takeuchi M; Shibanuma T; Isomura Y
    Chem Pharm Bull (Tokyo); 1998 Oct; 46(10):1538-44. PubMed ID: 9810691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A proposed common spatial pharmacophore and the corresponding active conformations of some TxA2 receptor antagonists.
    Jin B; Hopfinger AJ
    J Chem Inf Comput Sci; 1994; 34(4):1014-21. PubMed ID: 7929664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacophore modeling of diverse classes of p38 MAP kinase inhibitors.
    Sarma R; Sinha S; Ravikumar M; Kishore Kumar M; Mahmood SK
    Eur J Med Chem; 2008 Dec; 43(12):2870-6. PubMed ID: 18406015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of both NK1 and NK2 receptors in guinea-pig airways.
    McKee KT; Millar L; Rodger IW; Metters KM
    Br J Pharmacol; 1993 Oct; 110(2):693-700. PubMed ID: 7694756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists.
    Barreca ML; Gitto R; Quartarone S; De Luca L; De Sarro G; Chimirri A
    J Chem Inf Comput Sci; 2003; 43(2):651-5. PubMed ID: 12653534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stepwise development of structure-activity relationship of diverse PARP-1 inhibitors through comparative and validated in silico modeling techniques and molecular dynamics simulation.
    Halder AK; Saha A; Saha KD; Jha T
    J Biomol Struct Dyn; 2015; 33(8):1756-79. PubMed ID: 25350685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Construction of pharmacophore model of PARP-1 inhibitor].
    Zhang WT; Yan H; Jiang FC
    Yao Xue Xue Bao; 2007 Mar; 42(3):279-85. PubMed ID: 17520827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding the structural requirements in diverse scaffolds for the inhibition of P. falciparum dihydroorotate dehydrogenase (PfDHODH) using 2D-QSAR, 3D-pharmacophore and structure-based energy- optimized pharmacophore models.
    Aher RB; Roy K
    Comb Chem High Throughput Screen; 2015; 18(2):217-26. PubMed ID: 25543684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derivation of a 3D pharmacophore model for the angiotensin-II site one receptor.
    Prendergast K; Adams K; Greenlee WJ; Nachbar RB; Patchett AA; Underwood DJ
    J Comput Aided Mol Des; 1994 Oct; 8(5):491-512. PubMed ID: 7876897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New spiropiperidines as potent and selective non-peptide tachykinin NK2 receptor antagonists.
    Smith PW; Cooper AW; Bell R; Beresford IJ; Gore PM; McElroy AB; Pritchard JM; Saez V; Taylor NR; Sheldrick RL
    J Med Chem; 1995 Sep; 38(19):3772-9. PubMed ID: 7562907
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands.
    Charifson PS; Bowen JP; Wyrick SD; Hoffman AJ; Cory M; McPhail AT; Mailman RB
    J Med Chem; 1989 Sep; 32(9):2050-8. PubMed ID: 2527994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous modulation of excitatory amino acid responsiveness by tachykinin NK1 and NK2 receptors in the rat spinal cord.
    Chizh BA; Cumberbatch MJ; Birch PJ; Headley PM
    Br J Pharmacol; 1995 Jul; 115(6):1013-9. PubMed ID: 7582497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacophore mapping and in silico screening to identify new potent leads for A(2A) adenosine receptor as antagonists.
    Mustyala KK; Chitturi AR; Naikal James PS; Vuruputuri U
    J Recept Signal Transduct Res; 2012 Apr; 32(2):102-13. PubMed ID: 22384789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacophore Model for Wnt/Porcupine Inhibitors and Its Use in Drug Design.
    Poulsen A; Ho SY; Wang W; Alam J; Jeyaraj DA; Ang SH; Tan ES; Lin GR; Cheong VW; Ke Z; Lee MA; Keller TH
    J Chem Inf Model; 2015 Jul; 55(7):1435-48. PubMed ID: 26024410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacophore model of integrin alphavbeta3 antagonists].
    Cheng GY; Ni GH; Jiang FC
    Yao Xue Xue Bao; 2009 Apr; 44(4):379-85. PubMed ID: 19545055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. alpha,alpha-Cyclic aminoacids as useful scaffolds for the preparation of hNK(2) receptor antagonists.
    Sisto A; Altamura M; Cardinali F; D'Andrea P; Rossi C; Fattori D
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4841-4. PubMed ID: 17604625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacophore modeling and virtual screening to identify potential RET kinase inhibitors.
    Shih KC; Shiau CW; Chen TS; Ko CH; Lin CL; Lin CY; Hwang CS; Tang CY; Chen WR; Huang JW
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4490-7. PubMed ID: 21724393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential roles of neurokinin 1 and neurokinin 2 receptors in the development and maintenance of heat hyperalgesia induced by acute inflammation.
    Sluka KA; Milton MA; Willis WD; Westlund KN
    Br J Pharmacol; 1997 Apr; 120(7):1263-73. PubMed ID: 9105701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probing the conformation of the sugar transport inhibitor phlorizin by 2D-NMR, molecular dynamics studies, and pharmacophore analysis.
    Wielert-Badt S; Lin JT; Lorenz M; Fritz S; Kinne RK
    J Med Chem; 2000 May; 43(9):1692-8. PubMed ID: 10794686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacophore modeling of dual angiotensin II and endothelin A receptor antagonists.
    Xue WZ; Lü W; Zhou ZM; Wang ZL
    Yao Xue Xue Bao; 2009 Sep; 44(9):1002-8. PubMed ID: 20055175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.